Ligand Pharmaceuticals stock trades on Nasdaq, with Citigroup issuing buy ratings and a director selling shares.

The entities involved

• Ligand Pharmaceuticals →

  biopharmaceutical company based out of La Jolla, California

  • Ligand Pharmaceuticals committed funding and royalty rights to AvenCell Therapeutics, Inc.Sun 17:54
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Penguin Solutions, Inc. stock traded on Nasdaq, with Citigroup providing rating updates and legal filings made with the SEC.Jul 28
• Director Jason Haas sold shares of Ligand Pharmaceuticals on September 13, 2026, which traded on the Nasdaq.Sep 13
• Citigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Jun 19
• Citigroup provided analyst ratings and reports for ServiceTitan stock, which trades on Nasdaq.Aug 25
• Incannex Healthcare Inc. stock was traded on the Nasdaq exchange on June 29, 2026.Jun 30